Portfolio company
Volumetric
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company develops 3D bioprinting platforms and biomaterials for healthcare researchers to create human organ replacements and vascularised tissue models for drug testing.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Volumetric | 3D Systems
This company develops bioprinting technologies and vascularised human tissues for pharmaceutical researchers and medical institutions conducting drug testing and organ replacement research.
Cellink
This company develops 3D bioprinters and bioinks for researchers in academic, pharmaceutical and industrial laboratories to create human tissue models and organs.
Hooke Bio
This company develops a microfluidic platform using three-dimensional human tissue models for preclinical drug testing for pharmaceutical and biotechnology organisations.
Revalia
This company provides a platform for testing drug candidates on functional human organs to provide preclinical data for pharmaceutical and biotechnology firms.
Allevi
This company develops 3D bioprinters and bioinks for researchers in tissue engineering, drug development and regenerative medicine.
Photosynthetic
The company produces high-speed volumetric 3D printers for manufacturing complex microstructures used by researchers in life sciences, optics, and medical device development.
Dimension Bio
This company develops 3D-printed regenerative implants and tissue-like therapies to restore organ and tissue function for patients with disease, trauma, or ageing.
ScreenIn3D Limited
This company develops microfluidic lab-on-a-chip platforms for drug developers to test therapies on patient-derived three-dimensional tumour samples.
